Memscap SA
PAR:MEMS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.94
9.84
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Memscap SA
Cost of Revenue
Memscap SA
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Memscap SA
PAR:MEMS
|
Cost of Revenue
-€12.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
|
Sequans Communications SA
NYSE:SQNS
|
Cost of Revenue
-$9.7m
|
CAGR 3-Years
28%
|
CAGR 5-Years
11%
|
CAGR 10-Years
2%
|
|
|
TronicS Microsystems SA
PAR:ALTRO
|
Cost of Revenue
-€5.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Memscap SA
Glance View
MEMSCAP SA engages in the provision of innovative solutions based on micro-electro-mechanical technology. The company is headquartered in Crolles, Auvergne-Rhone-Alpes. The company went IPO on 2001-03-01. The firm operates in four market segments: Aerospace, Medical / Biomedical, Mass Market / Other Applications, and Optical Communications / Adaptive Optics. The firm's products include pressure sensors, pressure transducers, pressure switches, medical accessories, optical attenuators (chips), micro relays and Multi-User MEMS Processes, such as PolyMUMPs, SOIMUMPs, MetalMUMPs, and PiezoMUMPs. The firm's customers include Fortune 500 businesses, major research institutes and universities. The Company’s wholly owned subsidiaries include Laboratoires La Licorne SAS (France), MEMSCAP Inc (the United States) and MEMSCAP AS (Norway).
See Also
What is Memscap SA's Cost of Revenue?
Cost of Revenue
-12.1m
EUR
Based on the financial report for Sep 30, 2024, Memscap SA's Cost of Revenue amounts to -12.1m EUR.
What is Memscap SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-1%
Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Memscap SA have been -6% over the past three years , -3% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
